[Fig 2](#pone.0140415.g001){ref-type="fig"} is incorrect. The image that appears as [Fig 2](#pone.0140415.g001){ref-type="fig"} is a duplicate of Table 1. Please view the correct [Fig 2](#pone.0140415.g001){ref-type="fig"} below.

![Pooled risks according to dietary carotenoids intake and its blood levels.\
Dietary intake of α-carotene, β-carotene, lycopene and PCa risk(left), blood levels of α-carotene, β-carotene, lycopene and PCa risk(right).](pone.0140415.g001){#pone.0140415.g001}

[Fig 3](#pone.0140415.g002){ref-type="fig"} is incorrect. The image that appears as [Fig 3](#pone.0140415.g002){ref-type="fig"} is a duplicate of the correct [Fig 2](#pone.0140415.g001){ref-type="fig"}. Please view the correct [Fig 3](#pone.0140415.g002){ref-type="fig"} below.

![Association between blood α-carotene and lycopene levels and risk of advanced PCa.\
Advanced PCa was defined as stage III or IV or Gleason score ≥7.](pone.0140415.g002){#pone.0140415.g002}

[Fig 4](#pone.0140415.g003){ref-type="fig"} is incorrect. The image that appears as [Fig 4](#pone.0140415.g003){ref-type="fig"} is a duplicate of Table 2. Please view the correct [Fig 4](#pone.0140415.g003){ref-type="fig"} below.

![Dose-response relation plots between carotenoids consumption and risk of PCa.\
(A) Dietary lycopene intake(mg/day) and risk of PCa; (B) Blood lycopene levels (ug/dl) and risk of PCa; (C) Dietary α-carotene intake(mg/day) and risk of PCa. These relationships were estimated by using random-effects metaregression. Dotted lines represent the 95% CIs for the fitted trend.](pone.0140415.g003){#pone.0140415.g003}
